Open AccessEarly treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review
Author(s) -
Mazen Noureddin,
Suntje Sander-Struckmeier,
José M. Mato
Publication year - 2020
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v12.i2.46
Subject(s) - medicine , placebo , cholestasis , randomized controlled trial , gastroenterology , alkaline phosphatase , meta analysis , pathology , biochemistry , chemistry , alternative medicine , enzyme
S-adenosylmethionine (AdoMet) is a metabolically pleiotropic molecule used to treat intrahepatic cholestasis (IHC) and chronic liver diseases. While the efficacy of AdoMet has been demonstrated previously, it has not been systematically investigated within the early weeks of treatment.